#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=02.04.2023:
#Text=Oppfølging migrene.
1-1	0-10	02.04.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-22	Oppfølging	OVERLAP	TREATMENT	_	_	
1-4	23-30	migrene	_	_	_	_	
1-5	30-31	.	_	_	_	_	

#Text=Hodepinedagbok viser bedring med Sumatriptan, men fortsatt hyppige anfall.
2-1	32-46	Hodepinedagbok	BEFORE	TREATMENT	_	_	
2-2	47-52	viser	_	_	_	_	
2-3	53-60	bedring	OVERLAP[1]	CONDITION[1]	_	_	
2-4	61-64	med	OVERLAP[1]	CONDITION[1]	_	_	
2-5	65-76	Sumatriptan	OVERLAP[1]	CONDITION[1]	_	_	
2-6	76-77	,	_	_	_	_	
2-7	78-81	men	_	_	_	_	
2-8	82-90	fortsatt	_	_	_	_	
2-9	91-98	hyppige	OVERLAP[2]	CONDITION[2]	OVERLAP	2-3[1_2]	
2-10	99-105	anfall	OVERLAP[2]	CONDITION[2]	_	_	
2-11	105-106	.	_	_	_	_	

#Text=Nakkeproblematikk vedvarer tross fysioterapi.
3-1	107-124	Nakkeproblematikk	OVERLAP	CONDITION	_	_	
3-2	125-133	vedvarer	_	_	_	_	
3-3	134-139	tross	_	_	_	_	
3-4	140-151	fysioterapi	BEFORE	TREATMENT	_	_	
3-5	151-152	.	_	_	_	_	

#Text=Diskuterer forebyggende behandling.
4-1	153-163	Diskuterer	_	_	_	_	
4-2	164-176	forebyggende	_	_	_	_	
4-3	177-187	behandling	_	_	_	_	
4-4	187-188	.	_	_	_	_	

#Text=Starter Candesartan 8mg x1 som migreneprofylakse.
5-1	189-196	Starter	_	_	_	_	
5-2	197-208	Candesartan	AFTER[3]	TREATMENT[3]	_	_	
5-3	209-212	8mg	AFTER[3]	TREATMENT[3]	_	_	
5-4	213-215	x1	_	_	_	_	
5-5	216-219	som	_	_	_	_	
5-6	220-237	migreneprofylakse	_	_	_	_	
5-7	237-238	.	_	_	_	_	

#Text=Planlegger MR caput og cervicalcolumna for å utelukke patologi.
6-1	239-249	Planlegger	_	_	_	_	
6-2	250-252	MR	AFTER[4]	TREATMENT[4]	_	_	
6-3	253-258	caput	AFTER[4]	TREATMENT[4]	_	_	
6-4	259-261	og	_	_	_	_	
6-5	262-277	cervicalcolumna	AFTER	TREATMENT	_	_	
6-6	278-281	for	_	_	_	_	
6-7	282-283	å	_	_	_	_	
6-8	284-292	utelukke	_	_	_	_	
6-9	293-301	patologi	_	_	_	_	
6-10	301-302	.	_	_	_	_	

#Text=Ny kontroll om 4 uker.
7-1	303-305	Ny	_	_	_	_	
7-2	306-314	kontroll	AFTER	TREATMENT	BEFORE|BEFORE|BEFORE	6-2[4_0]|6-5|5-2[3_0]	
7-3	315-317	om	_	_	_	_	
7-4	318-319	4	_	_	_	_	
7-5	320-324	uker	_	_	_	_	
7-6	324-325	.	_	_	_	_	
